Time to initiation of fluconazole therapy impacts mortality in patients with candidemia: A multi-institutional study.
The DOI matches its Crossref record; 20 of the 20 references it cites were found in a registry or an index.
Abstract
BACKGROUND: Inadequate antimicrobial treatment is an independent determinant of hospital mortality, and fungal bloodstream infections are among the types of infection with the highest rates of inappropriate initial treatment. Because of significant potential for reducing high mortality rates, we sought to assess the impact of delayed treatment across multiple study sites. The goals our analyses were to establish the frequency and duration of delayed antifungal treatment and to evaluate the relationship between treatment delay and mortality. METHODS: We conducted a retrospective cohort study of patients with candidemia from 4 medical centers who were prescribed fluconazole. Time to initiation of fluconazole therapy was calculated by subtracting the date on which fluconazole therapy was initiated from the culture date of the first blood sample positive for yeast. RESULTS: A total of 230 patients (51% male; mean age +/- standard deviation, 56 +/- 17 years) were identified; 192 of these had not been given prior treatment with fluconazole. Patients most commonly had nonsurgical hospital admission (162 patients [70%]) with a central line catheter (193 [84%]), diabetes (68 [30%]), or cancer (54 [24%]). Candida species causing infection included Candida albicans (129 patients [56%]), Candida glabrata (38 [16%]), Candida parapsilosis (25 [11%]), or Candida tropicalis (15 [7%]). The number of days to the initiation of antifungal treatment was 0 (92 patients [40%]), 1 (38 [17%]), 2 (33 [14%]) or > or = 3 (29 [12%]). Mortality rates were lowest for patients who began therapy on day 0 (14 patients [15%]) followed by patients who began on day 1 (9 [24%]), day 2 (12 [37%]), or day > or = 3 (12 [41%]) (P = .0009 for trend). Multivariate logistic regression was used to calculate independent predictors of mortality, which include increased time until fluconazole initiation (odds ratio, 1.42; P < .05) and Acute Physiology and Chronic Health Evaluation II score (1-point increments; odds ratio, 1.13; P < .05). CONCLUSION: A delay in the initiation of fluconazole therapy in hospitalized patients with candidemia significantly impacted mortality. New methods to avoid delays in appropriate antifungal therapy, such as rapid diagnostic tests or identification of unique risk factors, are needed.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The mortality reduction associated with early antimicrobials appears strongest in patients with septic shock, where studies have reported a strong association between time to antibiotics and death in patients with septic shock but weaker associations in patients without septic shock (98,109,110).”
From Surviving Sepsis Campaign: International Guidelines for Management of Sepsis and Septic Shock 2021. (2021) · cites this paper as [109]
In the citing paper
“Blood cultures take an average of 2–3 days to grow Candida, or longer depending on the species.”
From Epidemiology of Invasive Candidiasis (2024) · cites this paper as [135]
In the citing paper
“Attributable mortality from IC remains high and increases with delays in treatment.”
From Epidemiology of Invasive Candidiasis (2024) · cites this paper as [135]
In the citing paper
“Some observational studies suggested that prompt initiation of appropriate empiric antifungal therapy may be associated with a reduction in mortality, however these studies do not prove a causal relationship between antifungal therapy and outcome, nor do they clarify the role of timing of treatment, and some other studies have failed to show this association [167, 171–173].”
From Surviving sepsis campaign: international guidelines for management of sepsis and septic shock 2021 (2021) · cites this paper as [171]
In the citing paper
“Multivariate analysis in this study also provided a strong association between delay in therapy and mortality.”
From Fungal Sepsis: Optimizing Antifungal Therapy in the Critical Care Setting (2011) · cites this paper as [46]
2 more claims about this paper
Create a free account to see every claim other papers make about this one.
Citations
Cites
Wisplinghoff, H., Bischoff, T., Tallent, S. M., Seifert, H., Wenzel, R. P., & Edmond, M. B. (2004) · Clinical Infectious Diseases · doi:10.1086/421946 · Cited by 4,496 · cited 11×
“By contrast, gram-positive bacteria, such as coagulase-negative staphylococci, S. aureus, and Enterococcus species, account for 60% of all BSIs [16].”
BackgroundInfluentialIbrahim, E. H., Sherman, G., Ward, S., Fraser, V. J., & Kollef, M. H. (2000) · Chest · doi:10.1378/chest.118.1.146 · Cited by 1,779 · cited 2×
“of inappropriate initial treatment [6].”
BackgroundMorrell, M., Fraser, V. J., & Kollef, M. H. (2005) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.49.9.3640-3645.2005 · Cited by 1,286 · cited 5×
“Delaying antifungal therapy appears to be a common practice, and the impact on mortality may be significant [8, 10].”
BackgroundResultInfluentialAttributable Mortality of Nosocomial Candidemia, Revisited
Gudlaugsson, O., Gillespie, S., Lee, K., Berg, J. V., Hu, J., Messer, S., Herwaldt, L., Pfaller, M., & Diekema, D. (2003) · Clinical Infectious Diseases · doi:10.1086/378745 · Cited by 1,140 · cited 2×
“Attributable mortality rates of 49% were also shown among patients with candidemia, compared with uninfected control subjects matched for age, sex, date of hospital admission, underlying diseases, length of time at risk, and type of surgical procedure [5].”
BackgroundPfaller, M. A., Diekema, D. J., Jones, R. N., Sader, H. S., Fluit, A. C., Hollis, R. J., Messer, S. A., & The SENTRY Participant Group (2001) · Journal of Clinical Microbiology · doi:10.1128/jcm.39.9.3254-3259.2001 · Cited by 521 · cited 1×
“[1].”
Morgan, J., Meltzer, M. I., Plikaytis, B. D., Sofair, A. N., Huie-White, S., Wilcox, S., Harrison, L. H., Seaberg, E. C., Hajjeh, R. A., & Teutsch, S. M. (2005) · Infection Control & Hospital Epidemiology · doi:10.1086/502581 · Cited by 437 · cited 2×
“attributable mortality remains 19%–49% [2, 5].”
Pfaller, M. A., Jones, R. N., Messer, S. A., Edmond, M. B., & Wenzel, R. P. (1998) · Diagnostic Microbiology and Infectious Disease · doi:10.1016/s0732-8893(97)00240-x · Cited by 331 · cited 10×
“By contrast, gram-positive bacteria, such as coagulase-negative staphylococci, S. aureus, and Enterococcus species, account for 60% of all BSIs [16].”
BackgroundInfluentialThe Impact of Candidemia on Length of Hospital Stay, Outcome, and Overall Cost of Illness
Rentz, A. M., Halpern, M. T., & Bowden, R. (1998) · Clinical Infectious Diseases · doi:10.1086/514955 · Cited by 310 · cited 1×
“of 8 cases per 100,000 population [2–4].”
Leinberger, D. M., Schumacher, U., Autenrieth, I. B., & Bachmann, T. T. (2005) · Journal of Clinical Microbiology · doi:10.1128/jcm.43.10.4943-4953.2005 · Cited by 155 · cited 1×
“Development of nonculture methods for the rapid diagnosis of candidemia in patients with BSI may also significantly improve the ability to quickly prescribe appropriate antifungal therapy [19, 20].”
Epidemiology and Prognostic Determinants of Bloodstream Infections in Surgical Intensive Care
Harbarth, S. (2002) · Archives of Surgery · doi:10.1001/archsurg.137.12.1353 · Cited by 135
Cited by
Items 701–800 of 1,000
Prevalence of Candida bloodstream isolates from patients in two hospitals in Vietnam
Bac, N. D., Le, T., Quang, L. B., Lực, N. K., Thi, T., Nagi, M., Yoshitsugu, M., Hà, H. T. T., Anh, Đ. Đ., Đỗ, Q., et al. (2019) · Iranian Journal of Microbiology · doi:10.18502/ijm.v11i2.1071 · Cited by 17
“A delay in the initiation of fluconazole therapy in hospitalized patients with candidemia is significantly impacted mortality (14).”
BackgroundWen, X., Chen, Q., Yin, H., Wu, S., & Wang, X. (2020) · Medicine · doi:10.1097/md.0000000000019194 · Cited by 32
“Traditional methods have a low positive detection rate and poor sensitivity and do not yield a rapid positive clinical diagnosis.([13]) Serological analysis primarily includes the 1,3-b-D-glucan test (G test), galactomannan test (GM test), and latex agglutination test.”
BackgroundBamba, Y., Nagano, K., Moro, H., Ogata, H., Hakamata, M., Shibata, S., Koizumi, T., Aoki, N., Ohshima, Y., Watanabe, S., et al. (2021) · PLoS ONE · doi:10.1371/journal.pone.0255172 · Cited by 11
“When treating IFIs, early diagnoses and prompt initiation of appropriate antifungal agents generally result in better outcomes [1].”
BackgroundInvasive Fungal Infections and Approaches to Their Diagnosis
Pfaller, M. A. (2015) · Methods in microbiology · doi:10.1016/bs.mim.2015.05.002 · Cited by 13
The Use of Procalcitonin as a Marker of Sepsis in Children
Mathew, B. (2013) · JOURNAL OF CLINICAL AND DIAGNOSTIC RESEARCH · doi:10.7860/jcdr/2013/4739.2753 · Cited by 11
Echinocandins in invasive candidiasis
Simon, J., Sun, H., Leong, H. N., Barez, M. Y., Huang, P., Talwar, D., Wang, J.-H., Mansor, M. M., Wahjuprajitno, B., Patel, A. K., et al. (2013) · Mycoses · doi:10.1111/myc.12085 · Cited by 12
Antifungal Stewardship: an Emerging Practice in Antimicrobial Stewardship
Andruszko, B., & Ashley, E. D. (2016) · Current Clinical Microbiology Reports · doi:10.1007/s40588-016-0039-1 · Cited by 12
Predictors of choice of initial antifungal treatment in intraabdominal candidiasis
Lagunes, L., Borgatta, B., Martín-Gómez, M. T., Rey-Perez, A., Antonelli, M. M., Righi, E., Merelli, M., Brugnaro, P., Dimopoulos, G., Garnacho‐Montero, J., et al. (2016) · Clinical Microbiology and Infection · doi:10.1016/j.cmi.2016.06.005 · Cited by 11
Cortegiani, A., Russotto, V., Raineri, S. M., Gregoretti, C., Rosa, F. G. D., & Giarratano, A. (2017) · Current Fungal Infection Reports · doi:10.1007/s12281-017-0288-3 · Cited by 13
Bordallo-Cardona, M. Á., Sánchez‐Carrillo, C., Bouza, E., Muñóz, P., Escribano, P., & Guinea, J. (2018) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.02004-18 · Cited by 12
Fatania, N., Fraser, M., Savage, M., Hart, J., & Abdolrasouli, A. (2015) · Journal of Clinical Pathology · doi:10.1136/jclinpath-2015-203029 · Cited by 11
Pang, Y., Ip, M., & You, J. H. S. (2016) · European Journal of Clinical Microbiology & Infectious Diseases · doi:10.1007/s10096-016-2796-4 · Cited by 12
Suárez-Urquiza, P., Pemán, J., Gordón, M., Favier, P., Muñoz-Brell, P., López-Hontangas, J. L., & Gaitán, A. C. R. (2024) · Journal of Fungi · doi:10.3390/jof10100674 · Cited by 11
“Early antifungal therapy is crucial, as it reduces the mortality associated with fungemia and its incidence [7–9] However, indiscriminate use of antifungals is expensive, can select for resistant species, and increases adverse drug reactions [10].”
BackgroundFarina, C., Russello, G., Andreoni, S., Bonetti, C., Conte, M., Fazi, P., Lombardi, G., Luzzaro, F., Manso, E., Marone, P., et al. (2012) · Medical Mycology · doi:10.3109/13693786.2011.648216 · Cited by 11
Association of cytokine gene polymorphisms with susceptibility to invasive candidiasis
Sun, Q., Tian, W. J., Xing, X. W., Gao, S., & Wang, S. B. (2015) · Genetics and Molecular Research · doi:10.4238/2015.june.18.29 · Cited by 10
“Some studies have shown that the immune response can influence the infection, comorbidities, and efficacy of pharmacologic therapy of patients with invasive candidiasis (Garey et al., 2006).”
BackgroundSoriano, À., Honoré, P. M., Cornely, O. A., Chayakulkeeree, M., Bassetti, M., Haihui, H., Dupont, H., Kim, Y. K., Kollef, M. H., Kullberg, B. J., et al. (2024) · Clinical Infectious Diseases · doi:10.1093/cid/ciae363 · Cited by 10
Kaskel, P., Wissing, Ballús, J., Bingold, T. M., Nocea, Krobot, Kumar, & Mavros, P. (2013) · Infection and Drug Resistance · doi:10.2147/idr.s38945 · Cited by 13
“11,27,30,31 Complete response rate for fluconazole in our study was comparable to studies that included all Candida spp. 20 but lower compared with those in which, for example, C. krusei was excluded.”
Prognostic factors of candidemia among nonneutropenic adults with total parenteral nutrition
Tsai, C., Lay, C.-J., Wang, C.-L., Lin, M.-L., & Yang, S.-P. (2011) · Journal of Microbiology Immunology and Infection · doi:10.1016/j.jmii.2011.04.002 · Cited by 12
Falces‐Romero, I., Cendejas‐Bueno, E., Laplaza-González, M., Escosa‐García, L., Schüffelmann, C., Calderón-Llopis, B., Pemán, J., de la Oliva, P., & García‐Rodríguez, J. (2018) · Medical Mycology Case Reports · doi:10.1016/j.mmcr.2018.05.006 · Cited by 10
Li, F., Yu, X., Ye, L., Zhou, G., Wang, L., & Luo, Y. (2019) · Medical Mycology · doi:10.1093/mmy/myy158 · Cited by 12
Guenter, S., Gorkiewicz, G., Halwachs, B., Kashofer, K., Thueringer, A., Wurm, P., Zollner‐Schwetz, I., Valentin, T., Prattes, J., Wunsch, S., et al. (2020) · Journal of Fungi · doi:10.3390/jof6020043 · Cited by 10
“The survival rate of invasive fungal infections (IFIs) is associated with the early initiation of antifungal therapy, since a delay in the administration of antifungals significantly impacts mortality [4,5].”
BackgroundBeredaki, M.-I., Arendrup, M. C., Andes, D. R., Mouton, J. W., & Meletiadis, J. (2021) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01292-20 · Cited by 11
“This would be detrimental for treating invasive infections, given that mortality increases every day if targeted therapy is delayed (24).”
BackgroundBeredaki, M.-I., Arendrup, M. C., Mouton, J. W., & Meletiadis, J. (2021) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2021.106291 · Cited by 10
Junco, S. J., Chehab, S., Giancarelli, A., Bowman, M. C., & Turner, R. B. (2021) · Infectious Diseases Research and Treatment · doi:10.1177/11786337211018722 · Cited by 10
“Hospital length of stayb 22 (12-35) 29 (20-53) .”
Hautala, N. M., Köykkä, H., Siiskonen, M., Saari, J., Kauranen, J., & Hautala, T. (2021) · BMJ Open Ophthalmology · doi:10.1136/bmjophth-2021-000837 · Cited by 10
Grant, V. C., Nguyen, K., Rodriguez, S., Zhou, A. Y., Abdul‐Mutakabbir, J. C., & Tan, K. K. (2022) · Tropical Medicine and Infectious Disease · doi:10.3390/tropicalmed7020023 · Cited by 10
“Early detection and initiation of appropriate empiric antifungal therapy is crucial for the management of IC [3,4].”
BackgroundWang, H., Wu, D., Han, H., Yue, J.-F., Zhang, F., Shan, T., Guo, H., & Yin, M. (2014) · Saudi Medical Journal · doi:10.15537/1658-3175.5900 · Cited by 12
Masterton, R. G., Casamayor, M., Musingarimi, P., van Engen, A., Zinck, R., Odufowora-Sita, O., & Odeyemi, I. A. O. (2013) · Journal of Medical Economics · doi:10.3111/13696998.2013.839948 · Cited by 11
Steuber, T. D., Butler, L., Sawyer, A., Chappell, R., & Edwards, J. D. (2021) · European Journal of Clinical Microbiology & Infectious Diseases · doi:10.1007/s10096-020-04144-8 · Cited by 10
“Timely antifungal therapy has been associated with reduced mortality from previous literature [3, 9].”
BackgroundInfluentialAnidulafungin: an evidence-based review of its use in invasive fungal infections
Vazquez, J. (2007) · Core evidence · doi:10.2147/ce.s7433 · Cited by 10
“Recent literature has shown that early initiation of antifungal therapy can improve patient outcomes, and considerable research is ongoing to define optimal therapy (Garey et al. 2006; Davis et al. 2007).”
Fun with fungi: a comprehensive review of common fungal organisms encountered in cytology
Torous, V. F., & Branda, J. A. (2022) · Journal of the American Society of Cytopathology · doi:10.1016/j.jasc.2022.11.004 · Cited by 10
Adult candidemia at a medical center in northern Taiwan: a retrospective study.
Tsai, C., Wang, C.-C., Kuo, H., Chiang, D.-H., Lin, M.-L., Liu, C.-Y., & Yang, S.-P. (2008) · PubMed · Cited by 10
Approaches to the early treatment of invasive fungal infection
Ito, J. I., Kriengkauykiat, J., Dadwal, S., Arfons, L. M., & Lazarus, H. M. (2010) · Leukemia & lymphoma/Leukemia and lymphoma · doi:10.3109/10428194.2010.496504 · Cited by 11
Smyth, J., Mullen, C. G., Jack, L., Collier, A., & Bal, A. M. (2018) · Journal de Mycologie Médicale · doi:10.1016/j.mycmed.2018.05.004 · Cited by 11
Haltmeier, T., Inaba, K., Effron, Z., Dollbaum, R., Shulman, I. A., Benjamin, E., Lam, L., & Δημητριάδης, Δ. (2015) · The American Surgeon · doi:10.1177/000313481508101031 · Cited by 9
Ghojoghi, A., Erfaninejad, M., Ahmadpour, E., Nazar, E., Barac, A. M., & Fatahinia, M. (2022) · Asian Pacific Journal of Tropical Medicine · doi:10.4103/1995-7645.356992 · Cited by 11
Fang, X., Su, C., Luo, Y., Pan, K., Lin, J., You-liang, S., Huang, Y., Hu, X., & Shen, Z. (2024) · Cytokine · doi:10.1016/j.cyto.2024.156803 · Cited by 9
Utility of Antifungal Susceptibility Testing and Clinical Correlations
Diekema, D. J., & Pfaller, M. A. (2011) · Humana Press eBooks · doi:10.1007/978-1-59745-134-5_8 · Cited by 10
Actualización en terapia antifúngica: nuevos fármacos e indicaciones
Fortün, J. (2011) · Enfermedades Infecciosas y Microbiología Clínica · doi:10.1016/s0213-005x(11)70042-8 · Cited by 17
Marchetti, O., Eggimann, P., & Calandra, T. (2010) · Current Opinion in Critical Care · doi:10.1097/mcc.0b013e32833e2629 · Cited by 9
Garbez, N., Mbatchi, L., Maseda, E., Luque, S., Grau, S., Wallis, S. C., Muller, L., Lipman, J., Roberts, J. A., Lefrant, J.-Y., et al. (2021) · Therapeutic Drug Monitoring · doi:10.1097/ftd.0000000000000874 · Cited by 9
Takazono, T., Izumikawa, K., Nagayoshi, Y., Tanaka, A., Mihara, T., Kosai, K., Saijo, T., Imamura, Y., Miyazaki, T., Seki, M., et al. (2011) · Japanese Journal of Infectious Diseases · doi:10.7883/yoken.64.116 · Cited by 11
“Although invasive candidiasis is associated with a high attributable mortality (5), the early diagnosis and rapid initiation of appropriate antifungal therapy reduces mortality (6,7).”
BackgroundCandida spp. DNA Extraction in the Age of Molecular Diagnosis
Codreanu, S. I., & Ciurea, C. N. (2023) · Microorganisms · doi:10.3390/microorganisms11040818 · Cited by 10
“40% versus over 40% when diagnosed later than 72 h [90].”
BackgroundGeneral Approaches for Direct Detection and Identification of Fungi
Ashbee, H. R. (2015) · ASM Press eBooks · doi:10.1128/9781555817381.ch116 · Cited by 9
Longer incubation times for yeast fungemia: importance for presumptive treatment
Paugam, A., Ancelle, T., Lortholary, O., & Bretagne, S. (2014) · Diagnostic Microbiology and Infectious Disease · doi:10.1016/j.diagmicrobio.2014.05.013 · Cited by 9
Time to Initiation of Antifungal Therapy for Neonatal Candidiasis
Lê, J., Tran, T. T. L., Bui, I., Wang, M. K., Vo, A., & Adler‐Shohet, F. C. (2013) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.02088-12 · Cited by 9
“In another study that evaluated 230 adults who were hospitalized for candidemia and received fluconazole stratified by the number of days to initiation of therapy relative to the time when the culture was obtained, a delay in therapy significantly impacted mortality (9).”
BackgroundKumar, A., & Funk, D. J. (2010) · Yearbook of Critical Care Medicine · doi:10.1016/s0734-3299(09)79323-2 · Cited by 9
Pagès, A., Iriart, X., Molinier, L., Georges, B., Berry, A., Massip, P., & Juillard‐Condat, B. (2017) · Value in Health · doi:10.1016/j.jval.2017.06.009 · Cited by 9
León-Borrás, R. D., DelPilar-Morales, E., Rivera-Pérez, N., Pallens-Feliciano, M., Tírado-Gómez, M., González‐Sepúlveda, L., & Bertrán‐Pasarell, J. (2017) · PubMed · Cited by 11
Utility of Panfungal PCR in the diagnosis of invasive fungal infections in febrile neutropenia
Srinivas, S., Kumari, P., & Gupta, D. K. (2021) · Journal of Family Medicine and Primary Care · doi:10.4103/jfmpc.jfmpc_2325_20 · Cited by 9
“of 230 patients with candidemia.[22] The results showed a significant trend for increased mortality with progressive delays in the initiation of fluconazole therapy.”
BackgroundChang, Y.-C., Chen, J.-S., Yin, C.-H., Lee, S. S.-J., & Chen, W.-C. (2022) · Journal of the Chinese Medical Association · doi:10.1097/jcma.0000000000000695 · Cited by 10
Chandenier, J., & Désoubeaux, G. (2014) · Bulletin de la Société de pathologie exotique · doi:10.1007/s13149-014-0376-3 · Cited by 11
“La rapidité d’intervention est également capitale et il a par exemple été montré que chaque jour de retard dans l’instauration d’un traitement adapté majorait de 10 % le taux de mortalité des patients candidémiques (10).”
BackgroundNucleic Acid Amplification Techniques
Lehmann, M. N., & Schmitz, R. P. H. (2015) · Wiley eBooks · doi:10.1002/9783527687978.ch3 · Cited by 9
Treatment strategies for central venous catheter infections
Sabatier, C., Ferrer, R., & Vallés, J. (2009) · Expert Opinion on Pharmacotherapy · doi:10.1517/14656560903133819 · Cited by 10
“Early initiation of antifungal therapy in patients with candidemia has a significant impact in mortality [99].”
BackgroundEmpiric Antifungal Therapy in Patients with Febrile Neutropenia
Ferrara, J. J., MacDougall, C., & Gallagher, J. C. (2011) · Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy · doi:10.1592/phco.31.4.369 · Cited by 10
Echinocandin Use in Hospitalized Patients: A Multi-institutional Study
Garey, K. W., Aitken, S. L., Dima-Ala, A., Beyda, N. D., Kuper, K. M., Xie, Y., & Koo, H. L. (2015) · The American Journal of the Medical Sciences · doi:10.1097/maj.0000000000000412 · Cited by 9
“Of candidemia episodes, 33% to 55% occur in intensive care units with mortality rates as high as 71%.(2,3) Candidemia in hospitalized patients has increased in frequency and has been associated with higher mortality, longer length of hospital stay and increased cost compared with bacterial bloodstream infections.”
BackgroundSelf-citationStrategies to manage antifungal drug resistance
Tseng, H.-K., & Perfect, J. R. (2011) · Expert Opinion on Pharmacotherapy · doi:10.1517/14656566.2010.517195 · Cited by 11
Tan, A. L., & Chan, K. S. (2008) · Annals of the Academy of Medicine Singapore · doi:10.47102/annals-acadmedsg.v37n10p841 · Cited by 9
“A. niger 12 BAL (9), lung tissue ( 1 ), nasal tissue (1), pus (1) unknown (1)”
BackgroundInfluentialTsai, M.-H., Lin, L.-C., Hsu, J., Lai, M., Huang, H., Chiang, M., & Lu, J. (2019) · Journal of Microbiology Immunology and Infection · doi:10.1016/j.jmii.2019.06.001 · Cited by 10
Antifungal Stewardship in Invasive Fungal Infections, a Systematic Review
Procacci, C., Marras, L., Maurmo, L., Vivanet, G., Scalone, L., & Bertolino, G. (2024) · Advances in experimental medicine and biology · doi:10.1007/5584_2024_798 · Cited by 9
Borman, A. M., & Johnson, E. M. (2013) · Current Fungal Infection Reports · doi:10.1007/s12281-013-0149-7 · Cited by 8
Prognostic factors for candidaemia in intensive care unit patients: a retrospective analysis
Kawano, Y., Togawa, A., Nakamura, Y., Mizunuma, M., Yamasaki, R., Hoshino, K., Nishida, T., & Ishikura, H. (2016) · Singapore Medical Journal · doi:10.11622/smedj.2016113 · Cited by 8
“Although the ideal time for starting antifungal drugs is not yet known, previous studies have found correlations between worse prognosis and delays in the initiation of antifungal therapy and inadequate empirical antifungal therapy.(11-13,26,27) These studies and our findings suggest that early antifungal administrati…”
BackgroundMethodHaydar, A. (2018) · IIUM Medical Journal Malaysia · doi:10.31436/imjm.v17i1.300 · Cited by 8
“This discovery is of a great concern as a delay in the initiation of antifungal therapy in hospitalized patients with candidaemia significantly impacted mortality.(13) Delaying antifungal therapy appears to be a common practice.”
BackgroundEsteves, P., Lima, S. L., Melo, A. S. D. A., Beirão, E. M., Nucci, M., & Colombo, A. L. (2020) · Mycoses · doi:10.1111/myc.13224 · Cited by 8
“Severity of illness APACHE II, mediana (range) 16,50 (5-38) Pitt score > 4b 21/62 (33.”
BackgroundHighly specific and rapid molecular detection of Candida glabrata in clinical samples
Hernández-Carreón, O., Hernández-Howell, C., Hernández-Hernández, G., Herrera-Basurto, M. S., González-Gómez, B. E., Gutiérrez‐Escobedo, G., García-Calderón, N. I., Barrón-Pastor, D., Peñas, A. D. L., & Castaño, I. (2021) · Brazilian Journal of Microbiology · doi:10.1007/s42770-021-00584-2 · Cited by 8
Updates in Laboratory Identification of Invasive Fungal Infection in Neonates
He, B., & Yang, Q. (2023) · Microorganisms · doi:10.3390/microorganisms11041001 · Cited by 10
“However, the positive rate of blood cultures is not high, and a significant proportion of patients with bloodstream infections have negative blood culture results [19,20].”
BackgroundLee, S.-C., Lee, C., Shih, H.-J., Huang, S.-H., Chiou, M., & See, L. (2013) · Journal of Microbiology Immunology and Infection · doi:10.1016/j.jmii.2013.09.006 · Cited by 8
Emergency management of sepsis: The simple stuff saves lives
Sweet, D. D., Marsden, J., Ho, K., Krause, C. M., & Russell, J. A. (2012) · Cited by 9
on behalf of the China-SCAN Team, Cui, N., Wang, H., Su, L., Qiu, H., Li, R., & Liu, D. (2017) · BMC Infectious Diseases · doi:10.1186/s12879-017-2207-1 · Cited by 10
Zaragoza, R., Ferrer, R., Llinares, P., Maseda, E., Rodríguez, A. H., Grau, S., & Quindós, G. (2017) · Revista Iberoamericana de Micología · doi:10.1016/j.riam.2017.03.008 · Cited by 8
Donato, L., González, T., Marilena Canales, R., Legarraga, P., García, P., & Ricardo Rabagliati, B. (2017) · Revista chilena de infectología · doi:10.4067/s0716-10182017000400340 · Cited by 9
The laboratory and clinical mycology
Pfaller, M. A., & McGinnis, M. R. (2009) · Elsevier eBooks · doi:10.1016/b978-1-4160-5680-5.00004-9 · Cited by 9
Kaito, S., Sekiya, N., Najima, Y., Suzuki, T., Wada, A., Adachi, H., Konuma, R., Kishida, Y., Nagata, A., Konishi, T., et al. (2019) · Bone Marrow Transplantation · doi:10.1038/s41409-019-0541-1 · Cited by 8
Aljeboori, Z., Gorelik, A., Jenkins, E., McFarlane, T., & Darvall, J. N. (2018) · Critical Care and Resuscitation · doi:10.1016/s1441-2772(23)00971-7 · Cited by 10
Vitale, R. G., & Nucci, M. (2013) · Current Fungal Infection Reports · doi:10.1007/s12281-013-0164-8 · Cited by 8
Biomarker-guided antifungal stewardship policies for patients with invasive candidiasis
Honarvar, B., Lankarani, K. B., Taghavi, M., Vahedi, G., & Mortaz, E. (2019) · Current Medical Mycology · doi:10.18502/cmm.4.4.385 · Cited by 8
“Therefore, timely diagnosis of IC greatly helps reach a better therapeutic outcome and enhanced survival rate [8, 9].”
BackgroundMethodInfluentialPruebas moleculares en el diagnóstico micológico
Rodríguez-Tudela, J. L., Cuesta, I., Gómez‐López, A., Alastruey‐Izquierdo, A., Bernal‐Martínez, L., & Cuenca‐Estrella, M. (2008) · Enfermedades Infecciosas y Microbiología Clínica · doi:10.1157/13128780 · Cited by 12
Guinea, J., Peláez, T., Rodríguez‐Créixems, M., Torres-Narbona, M., Muñóz, P., Alcalá, L., & Bouza, E. (2008) · Medical Mycology · doi:10.1080/13693780802415556 · Cited by 8
On track to limit antifungal overuse!
Eggimann, P., Lamoth, F., & Marchetti, O. (2009) · Intensive Care Medicine · doi:10.1007/s00134-009-1432-5 · Cited by 8
“Early recognition and appropriate management of IC are crucial for outcome [3, 4].”
BackgroundMuldoon, E. G., & Denning, D. W. (2014) · Clinical Infectious Diseases · doi:10.1093/cid/ciu080 · Cited by 8
“The importance of early treatment of IC has already been documented [6].”
Refractory versus resistant invasive aspergillosis
Arendrup, M. C., & Cordonnier, C. (2025) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkaf003 · Cited by 7
Lodise, T. P., Garey, K. W., Aram, J. A., Nathanson, B. H., & Redell, M. (2025) · Clinical Infectious Diseases · doi:10.1093/cid/ciaf472 · Cited by 8
Self-citationDual candidemia detected by nested polymerase chain reaction in two critically ill children
Negro, G. M. B. D., Delgado, A. F., Manuli, E. R., Yamamoto, L., & Okay, T. S. (2010) · Medical Mycology · doi:10.3109/13693786.2010.499375 · Cited by 8
Clinical Syndromes: Candida and Candidosis
Ruhnke, M. (2018) · Springer eBooks · doi:10.1007/978-3-319-92300-0_4 · Cited by 8
Zand, F., Mohsen, Davarpanah, M. A., Masjedi, M., Nikandish, R., Amanati, A., Afarid, M., Nafarieh, L., & Nami, M. (2016) · Bioscience Biotechnology Research Communications · doi:10.21786/bbrc/9.3/6 · Cited by 7
Farfour, É., Brun, C. L., Mizrahi, A., Bargain, P., Durieux, M.-F., Boquel, F., Corvec, S., Jeddi, F., Muggeo, A., Huguenin, A., et al. (2022) · Medical Mycology · doi:10.1093/mmy/myac021 · Cited by 7
Racial disparities among candidemic patients at a Southern California teaching hospital
Grant, V. C., Zhou, A. Y., Tan, K. K., & Abdul‐Mutakabbir, J. C. (2023) · Infection Control and Hospital Epidemiology · doi:10.1017/ice.2023.74 · Cited by 7
Speight, C. C., Williamson, J. E., Ebied, A. M., Medaris, L. A., McCurdy, L., & Hammer, K. L. (2023) · Open Forum Infectious Diseases · doi:10.1093/ofid/ofad388 · Cited by 7
“Application of best practice recommendations for the management of candidemia has been shown to significantly affect mortality in hospitalized patients with candidemia [10, 18, 19].”
BackgroundCabanilla, M. G., Briski, M. J., Bruss, Z. S., Saa, L., Vasquez, P. C., Rodriguez, C. N., Mitchell, J. A., Bernauer, M. L., Argyropoulos, C., Crandall, C. S., et al. (2023) · Renal Failure · doi:10.1080/0886022x.2023.2255680 · Cited by 7
“…in the initiation of antifungal therapy have been associated with an increased risk of death in patients with proven iFi, particularly candidemia [9,10]. as a result, empiric antifungal therapy is often used in the intensive care unit (icU) in patients who are found not to have iFi [7,11],…”
BackgroundYan, J.-Y., Lin, T.-H., Jong, Y.-T., Hsueh, J.-W., Wu, S.-H., Lo, H., Chen, Y., & Pan, C.-H. (2024) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2023.1278600 · Cited by 7
ISCCM Position Statement on the Management of Invasive Fungal Infections in the Intensive Care Unit
Kumar, S., Gupta, S., Chakrabarti, A., Pande, R. K., Bhattacharya, P., Bhosale, S. J., Kumar, A. A., Mishra, V. K., Sinha, S., & Reddy, P. K. (2024) · Indian Journal of Critical Care Medicine · doi:10.5005/jp-journals-10071-24747 · Cited by 7
Elhoufi, A. M., Ahmadi, A., Asnaashari, A. M. H., Davarpanah, M. A., Bidgoli, B. F., Moghaddam, O. M., Torabi-Nami, M., Abbasi, S., El-Sobky, M., Ghaziani, A., et al. (2014) · World Journal of Critical Care Medicine · doi:10.5492/wjccm.v3.i4.102 · Cited by 7
Angeletti, S., Gherardi, G., Florio, L. D., Avola, A., Crea, F., Riva, E., Vitali, M. A., Galluzzo, S., & Dicuonzo, G. (2013) · PubMed · Cited by 7
Grant, M. L., Parajuli, S., Deleon-Gonsalves, R., Potula, R., & Truant, A. L. (2016) · Canadian Journal of Infectious Diseases and Medical Microbiology · doi:10.1155/2016/4094932 · Cited by 7
Pharmacotherapy of Candida Infections with Echinocandins
Espinel-Ingroff, A. V., Canton, E., Martín‐Mazuelos, E., & Pemán, J. (2009) · Clinical Medicine Therapeutics · doi:10.4137/cmt.s2311 · Cited by 7
Diagnostic of Fungal Infections Related to Biofilms
Sanguinetti, M., & Posteraro, B. (2016) · Advances in experimental medicine and biology · doi:10.1007/5584_2016_9 · Cited by 7
“For example, how much early is the diagnosis of candidemia/invasive candidiasis (IC) or invasive aspergillosis (IA), and the consequent initiation of appropriate antifungal treatment (Garey et al. 2006; Parkins et al. 2007; Upton et al. 2007), so much favorable will be the outcome of these infections especially when t…”
BackgroundPepa, R. D., Cerchione, C., Pugliese, N., Colicchio, R., Salvatore, P., Sirignano, C., Soscia, E., Pagano, L., Sanguinetti, M., Pane, F., et al. (2018) · Supportive Care in Cancer · doi:10.1007/s00520-018-4138-9 · Cited by 7
“A late diagnosis leads to a delay in starting an effective antifungal therapy against Candida infection resulting in a severe morbidity and high mortality [3].”
BackgroundReview of techniques for diagnosis of catheter-related Candida biofilm infections
Nett, J. E., & Andes, D. R. (2008) · Current Fungal Infection Reports · doi:10.1007/s12281-008-0035-x · Cited by 9
“In addition, swift administration of antifungal therapy is critical in reducing mortality in patients with candidemia [ 10 ].”
BackgroundLongitudinal Evaluation of Plasma Cytokine Levels in Patients with Invasive Candidiasis
Wunsch, S., Zurl, C., Strohmaier, H. M., Meinitzer, A., Rabensteiner, J., Posch, W., Lass‐Flörl, C., Cornely, O. A., Pregartner, G., König, E., et al. (2021) · Journal of Fungi · doi:10.3390/jof7020101 · Cited by 8
Nosocomial candidemia in adults: Risk and prognostic factors
Gürcüoğlu, E., Akalın, H., Ener, B., Ocakoğlu, G., Sınırtaş, M., Akçağlar, S., Yılmaz, E., Evci, C., & Oral, H. B. (2010) · Journal de Mycologie Médicale · doi:10.1016/j.mycmed.2010.07.006 · Cited by 12
Metadata
- Authors
- Garey, K. W., Rege, M., Pai, M. P., Mingo, D. E., Suda, K. J., Turpin, R. S., & Bearden, D. T.
- Affiliations
- University of Houston (US)
- University of New Mexico (US)
- Baptist Memorial Health Care (US)
- University of Tennessee Health Science Center (US)
- Merck & Co., Inc., Rahway, NJ, USA (United States) (US)
- Oregon State University (US)
- Corresponding author
- Garey, Kevin W.
- Venue
- Clinical Infectious Diseases
- Publisher
- Oxford University Press (OUP)
- Published
- 2006-07
- Volume
- 43
- Issue
- 1
- Pages
- 25-31
- ISSN
- 1058-4838 (ISSN-L)
- 1537-6591
- OpenAlex
- W2164001967
- Semantic Scholar
- e1a67fd5e540307550577ea7a071370b075e943f
- Cited by
- 1,171
- References
- 20
- Citations by year
- 2026: 31 · 2025: 26 · 2024: 31 · 2023: 31 · 2022: 49 · 2021: 67 · 2020: 51 · 2019: 51 · 2018: 62 · 2017: 66 · 2016: 61 · 2015: 74 · 2014: 87 · 2013: 83 · 2012: 77
- FWCI
- 35.06
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Clinical Infectious Diseases (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Enzon Pharmaceuticals
- University of Houston
- Topics
- Health Sciences › Medicine › Infectious Diseases › Antifungal resistance and susceptibility
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Infective Endocarditis Diagnosis and Management
- Health Sciences › Medicine › Infectious Diseases › Fungal Infections and Studies
- Keywords
- candidemia, fluconazole, treatment delay, mortality, fungemia, Candida albicans, APACHE II score, mortality risk factors, hospitalized patients, Candida tropicalis, Candida parapsilosis, Candida glabrata, diabetes mellitus, cancer patients, sepsis
- MeSH terms
- Adult, Aged, Antifungal Agents, Candidiasis, Female, Humans, Length of Stay, Male, Middle Aged, Retrospective Studies, Time Factors, Cohort Studies, Fluconazole, Fungemia
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.